<i>In Vitro</i> Activity of the Siderophore Cephalosporin, Cefiderocol, against Carbapenem-Nonsusceptible and Multidrug-Resistant Isolates of Gram-Negative Bacilli Collected Worldwide in 2014 to 2016Meredith Hackel, Daniel F. Sahm, Roger Echols et al.|Antimicrobial Agents and Chemotherapy|2017Cited by 234
<i>In Vitro</i> Activity of the Siderophore Cephalosporin, Cefiderocol, against a Recent Collection of Clinically Relevant Gram-Negative Bacilli from North America and Europe, Including Carbapenem-Nonsusceptible Isolates (SIDERO-WT-2014 Study)Meredith Hackel, Daniel F. Sahm, Masakatsu Tsuji et al.|Antimicrobial Agents and Chemotherapy|2017Cited by 196
In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study)Krystyna M. Kazmierczak, Daniel F. Sahm, Masakatsu Tsuji et al.|International Journal of Antimicrobial Agents|2018Cited by 191